Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation

Open access
Oleinikovas, Vladas, Gainza, Pablo, Ryckmans, Thomas, Fasching, Bernhard, Thomä, Nicolas H. · 2024 · Annual Review of Pharmacology and Toxicology

Abstract

Thalidomide and its derivatives are powerful cancer therapeutics that are among the best-understood molecular glue degraders (MGDs). These drugs selectively reprogram the E3 ubiquitin ligase cereblon (CRBN) to commit target proteins for degradation by the ubiquitin-proteasome system. MGDs create novel recognition interfaces on the surface of the E3 ligase that engage in induced protein-protein interactions with neosubstrates. Molecular insight into their mechanism of action opens exciting opportunities to engage a plethora of targets through a specific recognition motif, the G-loop. Our analysis shows that current CRBN-based MGDs can in principle recognize over 2,500 proteins in the human proteome that contain a G-loop. We review recent advances in tuning the specificity between CRBN and its MGD-induced neosubstrates and deduce a set of simple rules that govern these interactions. We conclude that rational MGD design efforts will enable selective degradation of many more proteins, expanding this therapeutic modality to more disease areas.

Overview

Integrity signals

Registry

Crossref · 10.1146/annurev-pharmtox-022123-104147

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 64 references

Research works printed but not linked: 2

  1. Bradner J., 2021, Molecular glues for intractable targets
  2. Fischer Lab, 2020, Fischer lab's proteomics database

Cited by

See all 178

Metadata

Authors
Oleinikovas, V., Gainza, P., Ryckmans, T., Fasching, B., & Thomä, N. H.
Affiliations
  • Monte Rosa Therapeutics AG, Basel, Switzerland;
  • Sight and Life (CH)
  • Friedrich Miescher Institute (CH)
Venue
Annual Review of Pharmacology and Toxicology
Published
2024-01-23
Volume
64
Issue
1
Pages
291-312
ISSN
  • 0362-1642 (ISSN-L)
  • 1545-4304
OpenAlex
W4385858012
Cited by
178
References
64
Citations by year
2026: 53 · 2025: 92 · 2024: 31
FWCI
4.69
Type
journal article
Language
en
Open access
Locations
  • The Annual Review of Pharmacology and Toxicology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords
molecular glues, thalidomide, cereblon, targeted protein degradation, E3 ubiquitin ligase, G-loop, ubiquitin-proteasome system, drug design, cancer therapeutics, protein-protein interaction
MeSH terms
Humans, Thalidomide, Ubiquitin-Protein Ligases, Proteasome Endopeptidase Complex, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation. https://app.cochat.ai/papers/10.1146/annurev-pharmtox-022123-104147
The paper
Oleinikovas, V., Gainza, P., Ryckmans, T., Fasching, B., & Thomä, N. H. (2024). From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev-pharmtox-022123-104147

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.